Meta AnalysisID 6083
口服名贵藏药治疗缺血性脑卒中的系统评价与随机对照试验Meta分析
CRD42022337112
Tibetan medicine theory has unique advantages in the treatment of stroke with the features of multi-component, multi-link, multi-target. We aim to explore the efficacy and safety of oral Precious Tibetan Patent medicines
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 6083
- Evidence Id
- 14641
- Core Evidence Id
- 14641
- Source Meta Analysis Id
- 6065
- Herb2 Meta Analysis Id
- HBMA006065
- Crd Id
- CRD42022337112
- Title
- Precious Tibetan Patent medicines orally for ischemic stroke: a systematic review and meta-analysis of randomized controlled trials
- Review Question
- Tibetan medicine theory has unique advantages in the treatment of stroke with the features of multi-component, multi-link, multi-target. We aim to explore the efficacy and safety of oral Precious Tibetan Patent medicines for ischemic stroke according to current randomized controlled trials.
- Study Type Included
- The inclusion criteria were as follows: (1) randomized controlled trials; (2) definitively diagnosed with ischemic stroke ; (3) the treatment group was treated with oral precious Tibetan patent medicines singly or in conjunction with the conventional therapy or with positive drugs, while the control group was treated with conventional therapy or positive drugs. The exclusion criteria were as follows: a) case reports, reviews, animal experiments, cohort studies, and observational studies ; b) the interventions contained non-drug therapies or external Tibetan medicines; c) not describe the outcomes required; d)the results' data reported were deficient or unable to obtain original data; e) the duplicate articles.
- Condition Being Studied
- Stroke is the second leading cause of death worldwide and its burden is increasing rapidly. Ischemic stroke is is the most common type of stroke. Numerous randomized controlled trials have confirmed the efficacy of precious Tibetan Patent medicines in treating ischemic stroke.
- Participant
- Subjects who meet the clinical diagnostic criteria of ischemic stroke are not restricted by age, gender, race, duration of the illness.
- Animal
- Human Disease Modelled
- Intervention
- Oral precious Tibetan patent medicines singly or in conjunction with the conventional therapy or with positive drugs
- Comparator Control
- Placebo or the conventional therapy or positive drugs
- Main Outcome
- Clinical efficacy rate and adverse events.
- Outcome Measure
- Additional Outcome
- Neurological impairment score, Activities of daily living, Hemorheology(hematocrit, etc).
- Study Method
- Intervention, Meta-analysis, Methodology, Systematic review
- Keyword
- Foramen Ovale, Patent; Humans; Ischemic Stroke; Nonprescription Drugs; Randomized Controlled Trials as Topic; Tibet
- Contact
- Organisational Affiliation
- Funding Source
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- Chinese-Simplified, English
- Country
- Review Stage
- First Submission Date
- Registration Date
- Anticipated Start Date
- Anticipated Completion Date
- Title Cn
- 口服名贵藏药治疗缺血性脑卒中的系统评价与随机对照试验Meta分析
- Title En
- Precious Tibetan Patent medicines orally for ischemic stroke: a systematic review and meta-analysis of randomized controlled trials
- Bilingual Status
- complete